[特应性支气管哮喘患者的血清血管紧张素转换酶（SACE）]
[Serum angiotensin converting enzyme (SACE) in patients with atopic bronchial asthma].
作者信息
Frank-Piskorska A, Lypka A, Konieczna M
机构信息
II Kliniki Chorób Wewnetrznych Instytutu Medycyny Wewnetrznej.
出版信息
Pneumonol Alergol Pol. 1991;59(7-8):13-6.
The aim of the study was to assess serum ACE (S-ACE) activity in atopic bronchial asthma. S-ACE activity values were determined in 50 subjects (11 blood donors, 39 asthmatics) using the radioenzymatic method with Ventrex Laboratories kits. The authors did not find any differences between asthmatics in clinical remission, not receiving therapy, patients receiving prednisone (mean daily dose 10.0 +/- 2.5 mg) and healthy blood donors. In subjects with exacerbations of bronchospasm (not receiving steroids) S-ACE activity was significantly higher.
该研究的目的是评估特应性支气管哮喘患者的血清血管紧张素转换酶（S-ACE）活性。使用Ventrex Laboratories试剂盒的放射酶法测定了50名受试者（11名献血者，39名哮喘患者）的S-ACE活性值。作者未发现临床缓解期未接受治疗的哮喘患者、接受泼尼松（平均每日剂量10.0 +/- 2.5毫克）治疗的患者与健康献血者之间存在任何差异。在支气管痉挛加重的受试者（未接受类固醇治疗）中，S-ACE活性显著更高。
Zotero 插件